Latest hum. ProductsDetails
Product Name in the RMS: Rivastigmin Sandoz 9,5 mg/24 h - transdermales Pflaster
MR Number: AT/H/0483/002
Date of outcome: 18.11.2013
| Type of application | |
|---|---|
|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Known Active Substance Initial Application Generic Chemical Substance Prescription Only |
| Active Substances |
rivastigmine 9,5 mg/24 h |
| Form | Transdermal patch |
| MA Holder in the RMS |
Sandoz GmbH Biochemiestraße 10 A-6250 Kundl Austria Austria |
| RMS | Austria |
| Date of last change | 10.02.2021 |
| ATC-Code |
N06DA03 Rivastigmine |
| CMS Country | Domestic Product Name |
|---|---|
| Belgium | Rivastigmin Sandoz 9.5 mg/24u Pleister voor transdermaal gebruik |
| Denmark | |
| France | |
| Germany | Rivastigmin - Sandoz 9,5 mg / 24 h transdermales Pflaster |
| Greece | |
| Ireland | |
| Italy | |
| Netherlands | Rivastigmine Sandoz 9,5 mg/24 uur, pleisters voor transdermaal gebruik |
| Norway | Rigmin |
| Portugal | |
| Romania | Rivastigmină Sandoz 9,5 mg/24 ore plasture transdermic |
| Slovenia | |
| Spain | |
| Sweden | |
| United Kingdom |
| Documents | |
|---|---|
| PAR: | AT_H_0483_002_PAR.pdf (03.08.2015) |
| FinalSPC: | AT_H_0483_002_FinalSPC.pdf (16.10.2020) |
| FinalPL: | AT_H_0483_002_FinalPL.pdf (28.05.2019) |
| FinalLabelling: | AT_H_0483_002_FinalLabelling.pdf (16.10.2020) |
| Finalised Product Information: | AT_H_0483_002_FinalPI_1of3.pdf (18.11.2013) |
| Finalised Product Information: | AT_H_0483_002_FinalPI_2of3.pdf (18.11.2013) |
| Finalised Product Information: | AT_H_0483_002_FinalPI_3of3.pdf (18.11.2013) |
